Company Filing History:
Years Active: 2011-2013
Title: Innovations of Tianbao Chen in Peptide Research
Introduction
Tianbao Chen is a notable inventor based in Belfast, GB. He has made significant contributions to the field of peptide research, holding a total of 3 patents. His work focuses on the development of peptides that exhibit selective actions on smooth muscle, which has important implications for cardiovascular health.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Peptides, compositions and uses thereof." This patent describes an N-terminal hexapeptide fragment of maximakinin, known as QUB 698.8. This peptide demonstrates potent tissue-selective actions on smooth muscle, showing a high degree of selectivity for arterial smooth muscle over small intestinal smooth muscle. It causes potent relaxation of arterial smooth muscle while inducing less potent contraction of ileal smooth muscle. The potential applications of this invention include the treatment of diseases of the cardiovascular system and the promotion of angiogenesis.
Career Highlights
Tianbao Chen is affiliated with The Queen's University of Belfast, where he conducts his research. His innovative work in peptide development has positioned him as a key figure in the scientific community, particularly in the area of cardiovascular treatments.
Collaborations
He collaborates with esteemed colleagues such as David Hirst and Martin O'Rourke, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Tianbao Chen's contributions to peptide research are significant, particularly in the context of cardiovascular health. His patents reflect a commitment to advancing medical science through innovative solutions.